Bronchoconstriction models for LABA, LAMA & MABAs
This model allows for the assessment of bronchoprotective effects of novel bronchodilators to agonist challenge (Methacholine and or Histamine) induced bronchoconstriction in the anaesthetised guinea-pig.
Formoterol demonstrated significant inhibition on resistance and compliance of airway induced by histamine and methacholine in anaesthetised guinea pig.
Formoterol also showed significant bronchoprotection against 5µg/kg histamine and methacholine challenge.
Study Design | |
---|---|
Species/Strain | Dunkin Hartly Guinea Pig |
Model | Airway Bronchoconstriction |
Relevant Use | Screening and assessing the efficacy of new candidate LABA, LAMA and MABA's |
Readouts Available | Invasive Lung Function (terminal) assessment of AHR (airway hyper responsiveness) using the Flexivent system |
Study data generated by Labcorp Huntingdon Pharmacology.
Related Models
-
Bhas 42 Cell Transformation Assay (CTA)
Carcinogenicity, Discovery, Toxicology -
Asthma: Ovalbumin sensitization and challenge
Discovery -
Chlorine Induced Lung Injury
Discovery -
COPD: LPS + fMLP PK/PD model – Neutrophil Elastase Targets
Discovery -
COPD: Human Neutrophil Elastase Lung Hemorrhage Model
Discovery -
Bronchoconstriction models for LABA, LAMA & MABAs
Discovery -
Flu Model: H1N1 influenza lung infection model – viral COPD exacerbation
Discovery -
Model of Allergic Bronchopulmonary Aspergillosis (ABPA) in Mice
Discovery